Microencapsulation of Coenzyme Q10 and Bile Acids Using Ionic Gelation Vibrational Jet Flow Technology for Oral Delivery

References

• Orive G , PedrazJL. Highlights and trends in cell encapsulation. In: Therapeutic Applications of Cell Microencapsulation.PedrazJL, OriveG ( Eds). Springer, NY, USA, 1–4 (2010).
   Google Scholar
• Zanger UM . Introduction to drug metabolism. doi:10.1002/9783527630905.ch10 (2012).
   Google Scholar
• Jovic J , MilijasevicB , VukmirovicSet al. Pharmacokinetic and drug absorption profiles of the anti-hyperglycaemic agent gliclazide in oral tissue-targeted microcapsules in rats. Scripta Medical.51(1), 15–20 (2020).
   Google Scholar
• Odiba A , UkegbuC , AnunobiO , ChukwunonyelumI , EsemonuJ. Making drugs safer: improving drug delivery and reducing the side effect of drugs on the human biochemical system. Nanotechnol. Rev.5(2), 183–194 (2016).
   Web of Science ®Google Scholar
• Mooranian A , NegruljR , Al-SallamiHSet al. Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment. J. Microencapsul.32(2), 151–156 (2015).
   PubMed Web of Science ®Google Scholar
• Fan J , DeLannoy IaM. Pharmacokinetics. Biochem. Pharmacol.87(1), 93–120 (2014).
   PubMed Web of Science ®Google Scholar
• Pavlovic N , Golocorbin-KonS , EthanicMet al. Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles. Front Pharmacol.9, 1283 (2018).
   PubMed Web of Science ®Google Scholar
• Mikov M , BoniNS , Al-SalamiH , KuhajdaK , KevresanS , FawcettJP. Pharmacokinetics and hypoglycaemic effect of 3 alpha, 7 alpha-dihydroxy-12-oxo-5beta-cholanate (MKC) in diabetic rat. Febs J.273, 210–210 (2006).
   Web of Science ®Google Scholar
• Mikov M , BoniNS , Al-SalamiHet al. Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate, in healthy and diabetic rats. Eur. J. Drug Metab. Pharmacokinet32(1), 7–12 (2007).
   PubMed Web of Science ®Google Scholar
• Al-Salami H , ButtG , TuckerI , MikovM. Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics. Methods Find Exp. Clin. Pharmacol.30(2), 107–113 (2008).
   PubMedGoogle Scholar
• Al-Salami H , ButtG , TuckerIet al. Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet.34(1), 43–50 (2009).
   PubMed Web of Science ®Google Scholar
• Robertson D . First pass metabolism. Nurse Prescribing15(6), 303–305 (2017).
   Google Scholar
• Petrangolini G , RonchiM , FrattiniE , DeCombarieu E , AllegriniP , RivaA. A New Food-grade Coenzyme Q10 formulation improves bioavailability: single and repeated pharmacokinetic studies in healthy volunteers. Curr. Drug Deliv.16(8), 759–767 (2019).
   PubMed Web of Science ®Google Scholar
• Lopez-Lluch G , DelPozo-Cruz J , Sanchez-CuestaA , Cortes-RodriguezAB , NavasP. Bioavailability of Coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition57, 133–140 (2019).
   PubMed Web of Science ®Google Scholar
• Luo M , YangX , RuanX , XingW , ChenM , MuF. Enhanced stability and oral bioavailability of folic acid-dextran-Coenzyme q10 nanopreparation by high-pressure homogenization. J. Agric. Food Chem.66(37), 9690–9696 (2018).
   PubMed Web of Science ®Google Scholar
• Crane FL , HatefiY , LesterRL , WidmerC. Isolation of a quinone from beef heart mitochondria. BBA Biochim. Biophys. Acta25(C), 220–221 (1957).
   PubMedGoogle Scholar
• Molyneux SL , FlorkowskiCM , GeorgePMet al. Coenzyme Q10. J. Am. College Cardiol.52(18), 1435–1441 (2008).
   PubMed Web of Science ®Google Scholar
• Tran M , MitchellTM , KennedyD , GilesJ. Role of Coenzyme Q(10) in chronic heart failure, angina, and hypertension. Pharmacotherapy21(7), 797–806 (2001).
   PubMed Web of Science ®Google Scholar
• Littarru G , TianoL. Bioenergetic and antioxidant properties of Coenzyme Q10: recent developments. Mol. Biotechnol.37(1), 31–37 (2007).
   PubMed Web of Science ®Google Scholar
• Garrido-Maraver J , CorderoMD , Oropesa-ÁvilaMet al. Coenzyme Q10 therapy. Mol. Syndromol.5(3-4), 187–197 (2014).
   PubMedGoogle Scholar
• Fetoni AR , TroianiD , EramoSL , RolesiR , PaludettiTroiani G. Efficacy of different routes of administration for Coenzyme Q10 formulation in noise-induced hearing loss: systemic versus transtympanic modality. Acta Otolaryngol.132(4), 391–399 (2012).
   PubMed Web of Science ®Google Scholar
• Greenberg S , FrishmanW. Coenzyme-Q10 – a new drug for cardiovascular-disease. J. Clin. Pharmacol.30(7), 596–608 (1990).
   PubMed Web of Science ®Google Scholar
• Gupta S , KesarlaR , OmriA. Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm.2013 (2013).
   Google Scholar
• Gomez-Orellana I . Strategies to improve oral drug bioavailability. Expert Opin. Drug Deliv.2(3), 419–433 (2005).
   PubMedGoogle Scholar
• Tziona P , Theodosis-NobelosP , RekkaEA. Medicinal Chemistry approaches of controlling gastrointestinal side effects of non-steroidal anti-inflammatory drugs. endogenous protective mechanisms and drug design. Med. Chem.13(5), 408–420 (2017).
   PubMed Web of Science ®Google Scholar
• Moitessier N , PottelJ , TherrienEet al. Medicinal chemistry projects requiring imaginative structure-based drug design methods. Acc. Chem. Res.49(9), 1646–1657 (2016).
   PubMed Web of Science ®Google Scholar
• Sunoqrot S , HamedR , Abdel-HalimH , TarawnehO. Synergistic interplay of medicinal chemistry and formulation strategies in nanotechnology – from drug discovery to nanocarrier design and development. Curr. Top Med. Chem.17(13), 1451–1468 (2017).
   PubMed Web of Science ®Google Scholar
• Yan B . Impacts of nanotechnology on medicinal chemistry and drug discovery. Curr. Med. Chem.18(14), 2044 (2011).
   PubMed Web of Science ®Google Scholar
• Field LD , NagOK , SangtaniA , BurnsKE , DelehantyJB. The role of nanoparticles in the improvement of systemic anticancer drug delivery. Ther. Deliv.9(7), 527–545 (2018).
   PubMedGoogle Scholar
• Bertoni S , DolciLS , AlbertiniB , PasseriniN. Spray congealing: a versatile technology for advanced drug-delivery systems. Ther. Deliv.9(11), 833–845 (2018).
   PubMedGoogle Scholar
• Mooranian A , NegruljR , Al-SalamiH. Flow vibration-doubled concentric system coupled with low ratio amine to produce bile acid-macrocapsules of β-cells. Ther. Deliv.7(3), 171–178 (2016).
   PubMed Web of Science ®Google Scholar
• Tønnesen HH , KarlsenJ. Alginate in drug delivery systems. Drug Dev. Ind. Pharm.28(6), 621–630 (2002).
   PubMed Web of Science ®Google Scholar
• Pavlović N , Goločorbin-KonS , ĐanićMet al. Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles. Fronti. Pharmacol.9, 1283–1283 (2018).
   PubMed Web of Science ®Google Scholar
• Orive G , MariaHernández R , RodríGuezGascón Aet al. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol.22(2), 87–92 (2004).
   PubMed Web of Science ®Google Scholar
• Bocanegra R , LuisSampedro J , Gañán-CalvoA , MarquezM. Monodisperse structured multi-vesicle microencapsulation using flow-focusing and controlled disturbance. J. Microencapsul.22(7), 745–759 (2005).
   PubMed Web of Science ®Google Scholar
• Hajifathaliha F , MahboubiA , NematollahiL , MohitE , BolourchianN. Comparison of different cationic polymers efficacy in fabrication of alginate multilayer microcapsules. Asian J. Pharm. Sci.15(1), 95–103 (2020).
   PubMed Web of Science ®Google Scholar
• Esser-Kahn AP , SottosNR , WhiteSR , MooreJS. Programmable microcapsules from self-immolative polymers. J. Am. Chem. Soc.132(30), 10266–10268 (2010).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , TakechiR , JamiesonE , MorahanG , Al-SalamiH. New biotechnological microencapsulating methodology utilizing individualized gradient-screened jet laminar flow techniques for pancreatic beta-cell delivery: bile acids support cell energy-generating mechanisms. Mol. Pharm.14(8), 2711–2718 (2017).
   PubMedGoogle Scholar
• Mooranian A , NegruljR , TakechiR , JamiesonE , MorahanG , Al-SalamiH. Alginate-combined cholic acid increased insulin secretion of microencapsulated mouse cloned pancreatic beta cells. Ther. Deliv.8(10), 833–842 (2017).
   PubMed Web of Science ®Google Scholar
• Armin Mooranian RN , Al-SalamiH. Viability and topographical analysis of microencapsulated β-cells exposed to a biotransformed tertiary bile acid: an ex vivo study. Int. J. Nano Biomater. (2016) ( In Press).
   Google Scholar
• Mooranian A , NegruljR , JamiesonE , MorahanG , Al-SalamiH. Biological assessments of encapsulated pancreatic β-cells: their potential transplantation in diabetes. Cell. Mol. Bioeng.9(4), 530–537 (2016).
   Web of Science ®Google Scholar
• Szekalska M , PuciłowskaA , SzymańskaE , CiosekP , WinnickaK. Alginate: current use and future perspectives in pharmaceutical and biomedical applications. Int.J. Polym. Sci.2016(2016), 1–17 (2016).
   Google Scholar
• Mooranian A , NegruljR , Al-SalamiH. The influence of stabilized deconjugated ursodeoxycholic acid on polymer-hydrogel system of transplantable NIT-1 cells. J. Am. Assoc. Pharm. Sci.33(5), 1182–1190 (2016).
   Google Scholar
• Jyothi NVN , PrasannaPM , SakarkarSN , PrabhaKS , RamaiahPS , SrawanGY. Microencapsulation techniques, factors influencing encapsulation efficiency. J. Microencapsul.27, 187–197 (2010).
   PubMed Web of Science ®Google Scholar
• Wagle SR , KovacevicB , WalkerDet al. Alginate-based drug oral targeting using bio-micro/nano encapsulation technologies. Expert Opin. Drug Deliv. doi:10.1080/17425247.2020.1789587 (2020).
   PubMed Web of Science ®Google Scholar
• Angelina Angelova Borislav A . Dual and multi-drug delivery nanoparticles towards neuronal survival and synaptic repair. Neural Regen. Res.12(6), 886–889 (2017).
   PubMed Web of Science ®Google Scholar
• Zerkoune L , LesieurS , PutauxJ-Let al. Mesoporous self-assembled nanoparticles of biotransesterified cyclodextrins and nonlamellar lipids as carriers of water-insoluble substancesElectronic supplementary information (ESI) available: physico-chemical characteristics (Table S1), the chemical structure of Oil red O (OR) (Figure S1) and additional results from quasi-elastic light scattering, POM, UV-Visible spectroscopy and optical density measurements (Figure S2-S11). 12(36), 7539–7755 (2016).
   Google Scholar
• Guerzoni LPB , GuerzoniLPB , NicolasV , NicolasV , AngelovaA , AngelovaA. In vitro modulation of TrkB receptor signaling upon sequential delivery of curcumin-DHA loaded carriers towards promoting neuronal survival. Pharm. Res.34(2), 492–505 (2017).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , Al-SalamiH. The effects of ionic gelation- vibrational jet flow technique in fabrication of microcapsules incorporating β-cell: applications in diabetes. Curr. Diabetes Rev.13(1), 91–96 (2017).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , Al-SalamiH. Flow vibration-doubled concentric system coupled with low ratio amine to produce bile acid-macrocapsules of beta-cells. Ther. Deliv.7(3), 171–178 (2016).
   PubMed Web of Science ®Google Scholar
• Loh Q , WongY , ChoongC. Combinatorial effect of different alginate compositions, polycations, and gelling ions on microcapsule properties. Colloid Polym. Sci.290, 619–629 (2012).
   Web of Science ®Google Scholar
• Mørch YA , DonatiI , StrandBL , Skjåk-BraekG. Effect of Ca2+, Ba2+, and Sr2+ on alginate microbeads. Biomacromolecules7(5), 1471–1480 (2006).
   PubMed Web of Science ®Google Scholar
• Thu B , BruheimP , EspevikT , SmidsrødO , Soon-ShiongP , Skjåk-BrækG. Alginate polycation microcapsules: I. Interaction between alginate and polycation. Biomaterials17(10), 1031–1040 (1996).
   PubMed Web of Science ®Google Scholar
• Negrulj R , MooranianA , Al-SalamiH. Potentials and Limitations of Bile acids in Type 2 diabetes mellitus: applications of microencapsulation as a novel oral delivery system. J. Endocrinol. Diab. Mellitus1(2), 49–59 (2013).
   Google Scholar
• Mooranian A , NegruljR , Chen-TanNet al. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study. Drug Des. Devel. Ther.8, 1003–1012 (2014).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , MathavanSet al. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J. Pharm. Innovation9(2), 150–157 (2014).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , MathavanSet al. An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations. Pharm. Dev. Technol.20(6), 702–709 (2015).
   PubMed Web of Science ®Google Scholar
• Negrulj R , MooranianA , Chen-TanNet al. Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes. Artif Cells Nanomed. Biotechnol.44(5), 1290–1297 (2016).
   PubMed Web of Science ®Google Scholar
• Mamo JCL , LamV , Al-SalamiHet al. Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration. Ther. Deliv.9(10), 703–709 (2018).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , Chen-TanNet al. Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol. Drug Design. Dev. Ther.8, 1221–1230 (2014).
   PubMed Web of Science ®Google Scholar
• Strand BL , RyanTL , In'tVeld Pet al. Poly-L-Lysine induces fibrosis on alginate microcapsules via the induction of cytokines. Cell Transplant.10(3), 263–275 (2001).
   Web of Science ®Google Scholar
• Lim F , SunAM. Microencapsulated islets as bioartificial endocrine pancreas. Science210(4472), 908–910 (1980).
   PubMed Web of Science ®Google Scholar
• Mooranian A , ZamaniN , TakechiRet al. Modulatory nano/micro effects of diabetes development on pharmacology of primary and secondary bile acids concentrations. Curr. Diab. Rev. doi:10.2174/1389450121666200204115121 (2020).
   PubMed Web of Science ®Google Scholar
• Mooranian A , ZamaniN , MikovMet al. A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds. Saudi Pharm. J.28(2), 165–171 (2020).
   PubMed Web of Science ®Google Scholar
• Mooranian A , TackechiR , JamiesonE , MorahanG , Al-SalamiH. Innovative microcapsules for pancreatic beta-cells harvested from mature double-transgenic mice: cell imaging, viability, induced glucose-stimulated insulin measurements and proinflammatory cytokines analysis. Pharm. Res.34(6), 1217–1223 (2017).
   PubMed Web of Science ®Google Scholar
• Takka S , AcarturkF. Calcium alginate microparticles for oral administration: I: effect of sodium alginate type on drug release and drug entrapment efficiency. J. Microencapsul.16(3), 275–290 (1999).
   PubMed Web of Science ®Google Scholar
• Al-Zoubi NM , AlkhatibHS , ObeidatWM. Evaluation of hydrophilic matrix tablets based on Carbopol((R)) 971P and low-viscosity sodium alginate for pH-independent controlled drug release. Drug Dev. Ind. Pharm.37(7), 798–808 (2011).
   PubMed Web of Science ®Google Scholar
• Mooranian ANR , MikovM , Golocorbin-KonS , ArfusoF , Al-SalamiH. Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study. J. Microencapsul. (2015) ( In Press).
   Web of Science ®Google Scholar
• Nurunnabi M , KhatunZ , RevuriVet al. Design and strategies for bile acid mediated therapy and imaging. RSC Adv.6(78), 73986–74002 (2016).
   Web of Science ®Google Scholar
• Molinaro A , WahlströmA , MarschallH-U. Role of bile acids in metabolic control. Trends Endocrinol. Metab.29(1), 31–41 (2018).
   PubMed Web of Science ®Google Scholar
• Subuddhi U , MishraAK. Micellization of bile salts in aqueous medium: a fluorescence study. Colloids Surf. B Biointerfaces57(1), 102–107 (2007).
   PubMed Web of Science ®Google Scholar
• Roda A , MinutelloA , AngellottiMA , FiniA. Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC. J. Lipid Res.31(8), 1433 (1990).
   PubMed Web of Science ®Google Scholar
• Darkoh C , LichtenbergerLM , AjamiN , DialEJ , JiangZ-D , DupontHL. Bile acids improve the antimicrobial effect of rifaximin. Antimicrob. Agents Chemother.54(9), 3618–3624 (2010).
   PubMed Web of Science ®Google Scholar
• Zhou Y , MaxwellKN , SezginEet al. Bile acids modulate signaling by functional perturbation of plasma membrane domains. J. Biol. Chem.288(50), 35660–35670 (2013).
   PubMed Web of Science ®Google Scholar
• Woodhams L , Al-SalamiH. The roles of bile acids and applications of microencapsulation technology in treating Type 1 diabetes mellitus. Ther. Deliv.8(6), 401–409 (2017).
   PubMedGoogle Scholar
• Mooranian A , ZamaniN , MikovMet al. Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatment. Ther. Deliv.10(2), 99–106 (2019).
   PubMed Web of Science ®Google Scholar
• Mooranian A , RajWagle S , KovacevicBet al. Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study. Sci. Rep.10(1), 106–115 (2020).
   PubMed Web of Science ®Google Scholar
• Mihalj MP , KsenijaNK. Influence of bile acids on the adsorption of lidocaine and verapamil in an in vitro experiment. J. Serb. Chem. Soc.75(4), 433–440 (2010).
   Web of Science ®Google Scholar
• Zhang Z , LiH , XuG , YaoP. Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids. Drug Deliv.25(1), 1224–1233 (2018).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , ArfusoF , Al-SalamiH. Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: Formulation characterization and effects on production of insulin and inflammation in a pancreatic β-cell line. Artif. Cells Nanomed. Biotechnol.44(7), 1642–1653 (2016).
   PubMed Web of Science ®Google Scholar
• Ridlon JM , HarrisSC , BhowmikS , KangD-J , HylemonPB. Consequences of bile salt biotransformations by intestinal bacteria. Gut. Microbes7(1), 22–39 (2016).
   PubMed Web of Science ®Google Scholar
• Samstein RM , PericaK , BalderramaF , LookM , FahmyTM. The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials29(6), 703–708 (2008).
   PubMed Web of Science ®Google Scholar
• Lalic-Popovic M , VasovicV , MilijasevicB , Golocorbin-KonS , Al-SalamiH , MikovM. Deoxycholic acid as a modifier of the permeation of gliclazide through the blood brain barrier of a rat. J. Diabetes Res.2013, 598603 (2013).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , Chen-TanN , WattsG , ArfusoF , Al-SalamiH. An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer. Drug Des. Dev. Ther.8, 1673–1683 (2014).
   PubMed Web of Science ®Google Scholar
• Sreekanth V , MedatwalN , KumarSet al. Tethering of chemotherapeutic drug/imaging agent to bile acid-phospholipid increases the efficacy and bioavailability with reduced hepatotoxicity. Bioconjug. Chem.28(12), 2942–2953 (2017).
   PubMed Web of Science ®Google Scholar
• Patil S , PatilS , GawaliS , ShendeS , JadhavS , BasuS. Novel self-assembled lithocholic acid nanoparticles for drug delivery in cancer. RSC Adv.3(43), 19760–19764 (2013).
   Web of Science ®Google Scholar
• Wagle SR , WalkerD , KovacevicBet al. Micro-Nano formulation of bile-gut delivery: rheological, stability and cell survival, basal and maximum respiration studies. Sci. Rep.10(1), 7715 (2020).
   PubMed Web of Science ®Google Scholar
• Crumling MA , KingK , DuncanR. Cyclodextrins and iatrogenic hearing loss: new drugs with significant risk. Front. Cell. Neurosci.11, 335 (2017).
   PubMed Web of Science ®Google Scholar
• Loftsson T , DuchêneD. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm.329(1-2), 1–11 (2007).
   PubMed Web of Science ®Google Scholar
• Douroumis D , FahrA. Drug delivery strategies for poorly water-soluble drugs/edited by Dennis Douroumis and Alfred Fahr. Chichester, West Sussex: Wiley, Chichester, West Sussex1, 67–72 (2013).
   Google Scholar
• Brewster ME , LoftssonT. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev.59(7), 645–666 (2007).
   PubMed Web of Science ®Google Scholar
• Kurkov SV , LoftssonT. Cyclodextrins. Int. J. Pharm.453(1), 167–180 (2013).
   PubMed Web of Science ®Google Scholar
• Szejtli J . The metabolism, toxicity and biological effects of cyclodextrins. In: Cyclodextrains and Their Industry Use. ( Ed.). Editions de Sante, Paris, France, 173–210 (1987).
   Google Scholar
• Arima H , MotoyamaK , HigashiT. Potential therapeutic application of dendrimer/cyclodextrin conjugates with targeting ligands as advanced carriers for gene and oligonucleotide drugs. Ther. Deliv.8(4), 215–232 (2017).
   PubMedGoogle Scholar
• Peng L , LiuS , FengA , YuanJ. Polymeric nanocarriers based on cyclodextrins for drug delivery: host-guest interaction as stimuli responsive linker. Mol. Pharmaceutics14(8), 2475–2486 (2017).
   PubMed Web of Science ®Google Scholar
• Thakur SS , SollowayJ , StikkelmanA , SeyfoddinA , RupenthalID. Phase transition of a microemulsion upon addition of cyclodextrin – applications in drug delivery. Pharm. Dev. Technol.23(2), 167–175 (2017).
   PubMed Web of Science ®Google Scholar
• Bellringer ME , SmithTG , ReadR , GopinathC , OlivierP. β-Cyclodextrin: 52-Week toxicity studies in the rat and dog. Food Chem. Toxicol.33(5), 367–376 (1995).
   PubMed Web of Science ®Google Scholar
• García-Segovia P , Barreto-PalaciosV , BretónJ , Martínez-MonzóJ. Microencapsulation of essential oils using β-cyclodextrin: applications in gastronomy. J. Culinary Sci. Technol.9(3), 150–157 (2011).
   Google Scholar
• Ahmad M , AshrafB , GaniA , GaniA. Microencapsulation of saffron anthocyanins using β glucan and β cyclodextrin: microcapsule characterization, release behaviour & antioxidant potential during in-vitro digestion. Int. J. Biol. Macromol.109, 435–442 (2018).
   PubMed Web of Science ®Google Scholar
• Yallapu MM , JaggiM , ChauhanSC. β-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf. B Biointerfaces79(1), 113–125 (2010).
   PubMed Web of Science ®Google Scholar
• Zaghloul AA , GurleyB , KhanM , BhagavanH , ChopraR , ReddyI. Bioavailability assessment of oral Coenzyme Q10 formulations in dogs. Drug Dev. Ind. Pharm.28(10), 1195–1200 (2002).
   PubMed Web of Science ®Google Scholar
• Wahlqvist ML , WattanapenpaiboonN , SavigeGS , KannarD. Bioavailability of two different formulations of Coenzyme Q10 in healthy subjects. Asia Pac. J. Clin. Nutr.7(1), 37–40 (1998).
   PubMedGoogle Scholar
• Basak S , MondalS , DeySet al. Fabrication of β-cyclodextrin-mediated single bimolecular inclusion complex: characterization, molecular docking, in-vitro release and bioavailability studies for gefitinib and simvastatin conjugate. J. Pharm. Pharmacol.69(10), 1304–1317 (2017).
   PubMed Web of Science ®Google Scholar
• Sakchareonkeat P , HuangT-C , SuwannapornP , HsuanChiang Y , LiangHsu J , HanHong Y. Encapsulation efficiency of Coenzyme Q10-liposomes in alginate. Nutr. Food Sci.43(2), 150–160 (2013).
   Google Scholar
• Takahashi H , BungoY , MikuniKet al. Improved thermal property and absorption of Coenzyme Q10 in humans using cyclodextrin. J. Appl. Glycosci.57(3), 193–197 (2010).
   Google Scholar